Product
EMI-137
3 clinical trials
7 indications
Indication
Barrett's EsophagusIndication
Esophageal cancerIndication
Barrett Esophagus DysplasiaIndication
Papillary Thyroid CancerIndication
Lymph Node MetastasesIndication
Colorectal CancerIndication
Lymph Node MetastasisClinical trial
Molecular Fluorescence Endoscopy for the Detection of (Pre)Malignant Lesions in Barrett's Esophagus Using a Fluorescent Tracer 'EMI-137' Targeting c-Met: a Single-center Feasibility and Safety StudyStatus: Completed, Estimated PCD: 2019-03-25
Clinical trial
Detection of Thyroid Cancer and Central Lymph Node Metastases Using EMI-137 Enhanced Molecular Fluorescent Guided Imaging: a Multicentre Feasibility andStatus: Completed, Estimated PCD: 2019-12-31
Clinical trial
Intraoperative Imaging of Colon Cancer Using a Fluorescent Peptide (EMI-137) Against the c-Met ReceptorStatus: Completed, Estimated PCD: 2020-02-14